Showing results (151-160 of 189) with videos related to
Sort By:
Pageof 19
Brain Research. Developmental Brain Research|April 18, 1997
Cholinergic stimulation increases thrombin activity and gene expression in cultured mouse muscleG W Glazner, K Yadav, S Fitzgerald, et al.Annals of the New York Academy of Sciences|December 26, 1996
VIP regulation of embryonic growthJ M Hill, S K McCune, R J Alvero, et al.The Journal of Cell Biology|June 1, 1987
Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptideD E Brenneman, E A Neale, G A Foster, et al.Brain Research|December 11, 1992
Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide TJ Buzy, D E Brenneman, C B Pert, et al.Brain Research. Developmental Brain Research|June 8, 1993
Excitatory amino acid regulation of the enkephalin phenotype in mouse embryonic spinal cord culturesR W Summers, X R Wu, S C Fitzgerald, et al.Journal of Molecular Neuroscience : MN|January 1, 1989
Estrogen regulation of vasoactive intestinal peptide mRNA in rat hypothalamusI Gozes, H Werner, M Fawzi, et al.Journal of Neurobiology|September 23, 1997
Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's diseaseI Gozes, M Bachar, A Bardea, et al.Brain Research|August 14, 1999
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal deathD E Brenneman, J Hauser, C Y Spong, et al.Journal of Neurochemistry|April 1, 1990
Alpha 1-adrenergic receptor mediates arachidonic acid release in spinal cord neurons independent of inositol phospholipid turnoverR Y Kanterman, C C Felder, D E Brenneman, et al.Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug designI Gozes, O Perl, E Giladi, et al.Pageof 19